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Abstract
Background: Candida parapsilosis typically is a commensal of human skin. However, when host immune defense is
compromised or the normal microflora balance is disrupted, C. parapsilosis transforms itself into an opportunistic
pathogen. Candida-derived lipase has been identified as potential virulence factor. Even though cellular
components of the innate immune response, such as dendritic cells, represent the first line of defense against
invading pathogens, little is known about the interaction of these cells with invading C. parapsilosis. Thus, the aim
of our study was to assess the function of dendritic cells in fighting C. parapsilosis and to determine the role that
C. parapsilosis-derived lipase plays in the interaction with dendritic cells.
Results: Monocyte-derived immature and mature dendritic cells (iDCs and mDCs, respectively) co-cultured with
live wild type or lipase deficient C. parapsilosis strains were studied to determine the phagocytic capacity and
killing efficiency of host cells. We determined that both iDCs and mDCs efficiently phagocytosed and killed C.
parapsilosis, furthermore our results show that the phagocytic and fungicidal activities of both iDCs and mDCs are
more potent for lipase deficient compared to wild type yeast cells. In addition, the lipase deficient C. parapsilosis
cells induce higher gene expression and protein secretion of proinflammatory cytokines and chemokines in both
DC types relative to the effect of co-culture with wild type yeast cells.
Conclusions: Our results show that DCs are activated by exposure to C. parapsilosis, as shown by increased
phagocytosis, killing and proinflammatory protein secretion. Moreover, these data strongly suggest that C.
parapsilosis derived lipase has a protective role during yeast:DC interactions, since lipase production in wt yeast
cells decreased the phagocytic capacity and killing efficiency of host cells and downregulated the expression of
host effector molecules.
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Background
Candida parapsilosis is an emerging human pathogen
that is currently the second or third most commonly
isolated Candida species from blood cultures worldwide
[1-4]. C. parapsilosis typically is a commensal of human
skin and is considered to be of low pathogenicity in the
setting of intact host barriers. The species is notorious
for its capacity to form biofilms on catheters and other
implanted devices, for nosocomial spread by hand
carriage, and for persistence in the hospital environment
[1,3,5]. C. parapsilosis is of special concern in critically
ill neonates, causing more than one quarter of all inva-
sive fungal infections in low birth weight infants in the
UK [6] and North America [7,8], and it is a leading
cause of neonatal mortality. In low-birth weight neo-
nates, mortality rates are similar between infants with
invasive disease due to C. parapsilosis and C. albicans,
39 vs. 42%, respectively [6]. Hence, detailed knowledge
of C. parapsilosis interaction with the host has become
urgent. However, host immunity to C. parapsilosis infec-
tions represents an important, yet understudied area.
* Correspondence: gacsera@gmail.com
† Contributed equally
2Department of Microbiology, University of Szeged, Közép fasor 52, H-6726
Szeged, Hungary
Full list of author information is available at the end of the article
Nagy et al. BMC Microbiology 2011, 11:122
http://www.biomedcentral.com/1471-2180/11/122
© 2011 Nagy et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
Recognition and innate immune response against Can-
dida spp. is effected by both professional (eg. macro-
phages, neutrophils, dendritic cells) [9] as well as semi-
professional (eg. epithelial cells) [10] immune cells. The
most potent phagocytic cells of the immune system are
neutrophils and macrophages, and they are also consid-
ered as the prototypical phagocytic cells of pathogenic
Candida [11]. However, the strategic location of anti-
gen-presenting dendritic cells (DC) at epithelial surfaces
and in the skin, the primary sites of C. parapsilosis
occurrence, places DCs in the first line of defense
against invading yeast cells. It has recently been shown
that C. parapsilosis induces DC fungipod formation
[12], which is associated with immune recognition.
Importantly the fungipod response is species specific,
since the related fungal pathogens C. tropicalis and C.
albicans induce very few and no fungipods, respectively,
suggesting significant differences between the response
of DCs to different pathogenic Candida species. [12]. At
present, the role of DCs in C. parapsilosis pathogenesis,
such as the induction of cytokine gene and protein
expression, phagocytosis or fungicidal activity by DCs, is
poorly understood.
Although the clinical importance of C. parapsilosis is
growing, little is known about its virulence factors.
Secretion of extracellular hydrolytic enzymes can facili-
tate disease and lipases have been associated with C.
parapsilosis virulence [13], however the exact role of
this enzyme is still unknown. Putative roles for lipases
include the digestion of lipids for nutrient acquisition,
adhesion to host cells, synergistic interactions with other
enzymes, unspecific hydrolysis, initiation of inflamma-
tory processes by affecting immune cells, and self-
defense by lysing the competing microflora. We pre-
viously showed that C. parapsilosis secreted lipase
impacted the capacity of the fungus to grow in lipid rich
medium, to produce biofilm, and to survive in macro-
phages. The production of lipase was essential for C.
parapsilosis to attach, invade and damage reconstituted
oral epithelium, and to invade host tissues in a murine
infection model [13]. Concomitantly, we have evaluated
the role of Lip8, a key lipase in C. albicans, and recapi-
tulated our findings that lipases can be important viru-
lence factors in Candida [14].
The aim of our current study is to determine the in
vitro interaction of human monocyte-derived DCs with
wild type and lipase deficient C. parapsilosis cells.
Because immature and mature DCs (iDCs and mDCs,
respectively), show selective responsiveness to different
immune and cytokine stimuli we used both cell types in
our test system. We have determined that both DC
types exert phagocytic and fungicidal activities and pro-
duce T-helper (h) 1 type cytokines in response to C.
parapsilosis. Furthermore we analyzed the role of C.
parapsilosis lipase by using a lipase deficient mutant and
compared the phagocytic capacity and proinflammatory
protein production of both DC types.
Results
Human monocyte derived dendritic cells internalize lipase
deficient mutant yeast cells more efficiently
Although human DCs can phagocytose and eliminate C.
albicans cells [15], there is little information regarding
the outcome of the interactions between DCs and C.
parapsilosis cells. Therefore, we examined the ability of
human monocyte-derived DCs to phagocytose C. para-
psilosis. For this, iDCs and mDCs were incubated in sus-
pension with unopsonized FITC-labeled live C.
parapsilosis cells for various periods of time, and phago-
cytosis was quantified as described in Materials and
Methods.
Figure 1A and 1B show that iDCs ingested both wild
type and lipase deficient cells after a 1 h co-incubation.
Phagocytosis by DCs occurred as early as 30 min (data
not shown) after co-culture initiation, and after 1 h
29.4% of iDC and 24.8% of mDC had ingested C. para-
psilosis wild type cells (Figure 1D). In contrast, more
DCs ingested lipase deficient yeast, resulting in phagocy-
tosis rates of 44% (iDC) and 54.6% (mDC) (p value <
0.05) relative to wild type yeast in both DC types (Figure
1D). The phagocytic index data show that phagocytic
iDCs internalized an average of 3.2 C. parapsilosis wild
type yeast cells and mDCs ingested an average of 2.6
yeast cells (Figure 1E). The lack of the lipase production
significantly enhanced DC phagocytic index resulting in
average indices of 5.7 and 4.6 for iDCs and mDCs,
respectively (p value < 0.05) relative to wild type yeast
(Figure 1E). To validate and further quantify the phago-
cytosis percentages of DCs, we also analyzed C. parapsi-
losis phagocytosis by human DCs using FACS. The
FACS results correlated to that achieved by microscopy.
FACS showed that 29% of iDCs phagocytosed wild type
C. parapsilosis yeast cells and 47% ingested lipase defi-
cient yeast cells (Figure 1C). Similarly, 27% of mDCs
ingested wild type yeast cells and 51% phagocytosed
lipase deficient yeast cells (Figure 1C).
iDCs and mDCs efficiently kill C. parapsilosis yeast cells
To assess whether phagocytosis of C. parapsilosis cells
results in the activation of the antifungal effector
machinery in iDCs and mDCs, we performed killing
assays using DC co-cultures with C. parapsilosis wild
type and lipase deficient yeast. The results (Figure. 1F)
showed that both iDCs and mDCs were able to effi-
ciently kill C. parapsilosis by 3 h post-infection. iDCs
and mDCs killed 12% and 13.2% of wild type C. parapsi-
losis yeast cells, respectively. Furthermore, we found that
23% and 38.3% of lipase deficient yeast cells were killed
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Figure 1 C. parapsilosis functionally activates monocyte-derived dendritic cells resulting in increased phagocytosis and killing
efficiency. Panels A and B show representative images of iDCs incubated with unopsonized FITC-labeled wild type (Panel A) and lipase
deficient (Panel B) yeast cells at 1 h post-infection. Note that the majority of host cells express CD83, a dendritic cell marker. Panel C shows the
FACS plots of DCs infected with wild type (Cp wt) or lipase deficient (Cp lip-/-) yeasts at 1 h post-infection. Data on Panels D and E shows the
phagocytosis of DCs and are presented as the percent of ingesting cells (percent of DCs containing at least one ingested yeast cell; Panel D)
and the phagocytic index (total number of ingested yeast/100 DCs; Panel E). Panel F represents the fungicidal efficiency of DCs, infected with wt
or lip-/- C. parapsilosis. Panel G shows representative images of DCs incubated with unopsonized FITC-labeled wild type (Cp wt) or lipase
deficient (Cp lip-/-) yeasts at 1 h post-infection. Lysosomes were visualized by LysoTracker Red. Asterisks show the co-localization of mature
lysosomes (red) and phagocytosed yeast cells (green). Data on panel H shows the percentage of the dead-cells as determined by protease
activity at 1 h post-infection as compared to the untreated control cells. The data on Panels D-E and H are represented as mean ± SEM of six
and two experiments with different donors, respectively. DAPI - 4’,6-diamidino-2-phenylindole; wt - wild type; lip-/- - lipase deficient. Scale bars:
panels A and B: 20 μm; panel G: 5 μm.
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by iDCs and mDCs, respectively, which was significantly
higher compared to that of the wild type C. parapsilosis
(p value < 0.05).
In another series of experiments, we have monitored
the viability of DCs after infection with C. parapsilosis
by measuring the protease activity of the co-cultures.
Strikingly, we have found significantly increased number
of dead DCs following infection with lipase deficient
yeasts compared to uninfected DCs. Increased numbers
of dead DCs were present as early as 1 h post-lipase
deficient infection (Figure 1H) with only ~10% of DCs
remaining viable 24 h post-infection (data not shown).
In contrast, DCs infected with wild type yeast cells
showed decreased protease activity after 1 h of co-incu-
bation (Figure 1H) with ~50% of DCs still viable at 24 h
post-infection. We have obtained similar results when
using Trypan blue labeling (data not shown).
Numerous species of the Candida genus form pseudo-
hyphae as an effort to avoid killing by phagocytic cells.
Our data demonstrate that DCs less efficiently kill lipase
deficient compared to wild type C. parapsilosis and sug-
gest that wild type yeast cells, at least partially, escape
DC immune response. A possible escape mechanism
could be pseudohyphae formation. We have monitored
the pseudohyphae formation of C. parapsilosis in DC-
fungi co-culture and determined that C. parapsilosis
does not form pseudohyphae in our model (Figure 1A,
B and data not shown).
Another mechanism by which pathogens modify the
immune response of the host is altering lysosome matura-
tion. In order to test if C. parapsilosis lipase decreases the
phago-lysosome maturation, we have performed labeling
with LysoTracker Red, a weakly basic amine that selec-
tively accumulates in acidic compartments such as lyso-
some. We have observed lysosome maturation in both DC
types after infection with wild type and lipase deficient
yeast cells (Figure 1G), but there was a decreased number
of mature lysosomes in both iDCs and mDCs infected
with wild type yeast (Figure 1G).
Production of IL-1a, IL-6, TNFa, and CXCL8 by iDCs and
mDCs exposed to wild type or lipase deficient C.
parapsilosis
The outcome of encounters between antigen-bearing
APCs and naive T cells depends, in part, on the nature of
the proinflammatory proteins released locally by the
APCs. Proinflammatory cytokines and chemokines, such
as IL-1a, IL-6, TNFa, and CXCL8, secreted by various
cell types play a fundamental role in attracting neutro-
phils and T cells to the place of skin infection. Therefore,
we determined the pattern of the production of the
above mentioned four molecules in DCs exposed to wild
type or lipase deficient C. parapsilosis by monitoring
gene expression and protein secretion using qualitative
real-time (QRT)-PCR, cytokine-specific ELISAs, and
Luminex Fluorokine Multianalyte Profiling (MAP) assays.
For gene expression studies, cells were harvested at 1
and 24 h post-infection in order to monitor the early
and late effects of the infection, respectively. QRT-PCR
results revealed that the expression of nearly all of the
four proinflammatory genes was significantly higher
upon infection with C. parapsilosis cells in comparison
to the non-stimulated DC populations (p < 0.05), while
the expression of TNFa of iDCs infected with wild type
yeast cells and IL-6 of mDCs were not increased signifi-
cantly (Figure 2). Although, IL-1a transcripts were simi-
larly elevated in iDCs at 1 h post-infection with either
wild type or lipase deficient C. parapsilosis, the increase
was significantly greater with the lipase deficient yeast
cells (p < 0.05) (Figure 2A). At 24 h, the expression
levels with either type of C. parapsilosis were similarly
increased (Figure 2B). In comparison, mDCs stimulated
with lipase deficient cells did not show statistically sig-
nificant upregulation of IL-1a transcript at 1 h relative
to wild type, however the mRNA level increased by
almost 35 fold at 24 h (p < 0.05). The IL-6 gene was 30
fold upregulated in iDCs infected with lipase deficient
cells compared to wild type yeast at 1 h post-infection
(p = 0.002), although there were no differences at 24 h
or during infection of mDCs. Interestingly, the TNFa
transcript progressively diminished upon exposure to
wild type yeast cells, whereas it was upregulated in iDCs
infected with lipase deficient yeast cells. Lipase deficient
yeast induced significantly higher CXCL8 gene expres-
sion at both time points in iDCs (p < 0.05), whereas
mDCs increased CXCL8 mRNA levels only at 24 h
post-infection (p < 0.05).
For protein measurements, cell culture supernatants
were collected at 24 and 48 h post-infection in order to
allow protein translation to occur. We detected signifi-
cantly higher amounts of IL-1a in co-cultures of lipase
deficient cells and iDC at 24 h (p value < 0.05), but this
difference was not significant at 48 h (Table 1). In con-
trast, mDCs infected with lipase deficient yeast secreted
significantly more IL-1a protein at both time points (p
value < 0.05) (Table 2). Consistent with the gene expres-
sion, we detected high levels of secreted IL-6 in both
iDCs (Table 1) and mDCs (Table 2) at 24 and 48 hours.
Similarly, an elevated secretion of TNFa occurred in
response to lipase deficient cells at both time points
with iDCs (Table 1); however, mDCs produced more
TNFa only after 24 h (Table 2). Comparable levels of
CXCL8 were measured at 24 h and 48 h after exposure
to wild type or lipase deficient cells by both DC popula-
tions (Table 1 and 2). These results indicate that, upon
exposure to C. parapsilosis wild type or lipase deficient
yeast, iDCs and mDCs differentially produce IL-1a, IL-6
and TNFa.
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Discussion
The phagocytic capacity of macrophages and dendritic
cells is an important feature during microbial infection,
because the outcome of the interaction of phagocytic
cells with fungal pathogens influences the susceptibility
of the host to the infection [16,17]. In this work we
demonstrate that the emerging fungal pathogen C. para-
psilosis can be efficiently phagocytosed and killed by
human monocyte derived dendritic cells. Our results
showed that after 1 h co-incubation 29.4% of iDC and
24.8% of mDC had ingested C. parapsilosis wild type
cells. Interestingly, in a comparable study, approximately
Table 1 The profile of proinflammatory cytokine and chemokine secretion of iDCs in response to C. parapsilosis
iDC (24 h)
(pg/ml) unstimulated Cp wt Cp lip-/-
IL-1 a 9.38† (8.20-11.19) 10.01 (8.34-11.17) 23.60# (19.88-26.74)
IL-6 175.77 (48.34-252.62) 3059.61 (1689.8-5880.12) 5636.54# (2792.25-7915.07)
TNF a 74.36 (55.71-115.78) 624.47 (522.57-736.08) 2836.59# (2822.29-3147.02)
CXCL8 794.23 (162.80-1226.77) 3622.8 (2047-5297.31) 3023.9 (1226.41-5297.31)
iDC (48 h)
(pg/ml) unstimulated Cp wt Cp lip-/-
IL-1 a 7.85 (5.05-12.31) 15.45 (8.34-21.56) 22.14 (19.88-26.74)
IL-6 3573.23 (3201.12-4752.01) 5238.9 (3767.13-6082.85) 6968.16# (5398-8938.58)
TNF a 154.92 (115.71-194.82) 2342.12 (649.76-4333.62) 3947.27# (2433.01-5393.78)
CXCL8 1103.05 (656.02-1473.77) 1615.33 (942.11-1756.85) 1824.31 (1226.41-2491.06)
n = 8 independent blood donors
Immature dendritic cells were stimulated with C. parapsilosis wild type (Cp wt), lipase deficient (Cp lip-/-) cells or left unstimulated. Secretion of IL-1a, IL-6, TNFa
or CXCL8 by iDCs was determined by Luminex analyzer or ELISA at 24 h and 48 h post-infection. †: medians (interquartile ranges) # p < 0.05
Figure 2 C. parapsilosis induces the expression of proinflammatory cytokines and chemokines in DCs. Quantitative reverse transcriptase
polymerase chain reaction (QRT-PCR) analysis of IL-1a, IL-6, TNFa and CXCL8 gene expression in iDCs (Panels A and B) and mDCs (Panels C and
D) at 1 h (Panels A and C) and 24 h (Panels B and D) post-infection. DCs were infected with wild type (white columns) or lipase deficient (grey
columns) C. parapsilosis. Expression levels were normalized and compared to the 18S rRNA and the fold change value was calculated using the
ΔΔCT method. All measurements were preformed in duplicate for each experiment with at least three biological replicates. * p < 0.05, ** p =
0.002; wt - wild type; lip-/- - lipase deficient
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60% of a given iDC population phagocytose C. albicans
[9] thus, C. parapsilosis cells induce less phagocytosis in
comparison to C. albicans. In addition, we also observed
that lipase deficient C. parapsilosis cells were more effi-
ciently ingested by iDCs and mDCs relative to wild type
yeast. The microscopy and FACS results demonstrating
avid DC phagocytosis of both wild type and lipase defi-
cient yeast is consistent with an activated phenotype of
these host effector cells. Moreover, the enhanced phago-
cytosis of lipase deficient C. parapsilosis by DCs relative
to wild type yeast cells suggests that lipase interferes
with efficient DC activation.
Dendritic cells are able to kill internalized fungal cells.
The in vitro infections of DCs resulted in a 12% killing
of C. parapsilosis wild type cells. This result is compar-
able with that of C. albicans (13.6 ± SD 5.4%) [15].
Moreover, DCs did not kill C. albicans cells as effi-
ciently as monocytes or macrophages [15], and the C.
albicans findings and our results are consistent with the
concept that the function of DC is to present candidal
antigens to T-cells [18] rather than to eliminate the
microorganism. Notably, our data showed a significantly
elevated killing capacity of human dendritic cells against
lipase deficient C. parapsilosis strain. In summary, DCs
can effectively phagocytose C. parapsilosis, but the capa-
city to kill the yeast cells is less than that of macro-
phages [19] and according to our recent results, fungal
lipase suppresses the fungicidal activity of DCs.
The mechanisms involved in intracellular pathogenesis
are diverse. Among fungi, the most studied intracellular
pathogen is Histoplasma capsulatum, which is able to
impair phagosome-lysosome fusion [20,21]. In the case
of C. parapsilosis wild type strain, we observed that
there is a defect in the maturation of the DC phago-
lysosome using lysosomal markers of this process. This
finding is in agreement with the related species C. albi-
cans, where alterations of phagosome maturation and
acidification defects have been described [22,23]. The
lipase deficient mutants showed higher co-localization
with lysotracker stain, suggesting more frequent phago-
lysosome fusion and compartment acidification. In addi-
tion, our findings highlight that secreted fungal lipases
appear to have a role in the protective mechanisms
against the host intracellular killing processes.
The immune system may be activated by the recogni-
tion of nonself molecules of infectious agents or by
recognition of danger signals that include host mole-
cules released by damaged host cells [24]. It is proposed
that the two models are compatible, which may also be
the case in our model: both C. parapsilosis strains
induced the expression of chemotactic molecules, in
addition, DCs infected with lipase deficient yeast showed
increased cell death which is known to be accompanied
by the release of danger signals [25]. Consequently, we
propose that DCs infected with lipase deficient yeast
cells activate more robust immune response.
Although both wild type and lipase deficient C. para-
psilosis induced strong, time-dependent activation of
pro-inflammatory genes such as IL-1a, IL-6, TNF-a,
and CXCL-8 in both DC types, lipase deficient yeast
induced significantly higher gene expression of effector
molecules. Since locally produced chemotactic factors
are presumed to mediate the sequence of events leading
to the infiltration of immune cells at inflammatory sites,
local expression of pro-inflammatory mediators after
contact with C. parapsilosis could have an initiator role
in the attraction of additional immune cells to the sites
of infection. This is supported by the fact that CXCL8 is
one of the most potent neutrophil chemoattractants [26]
that affects not only the recruitment of neutrophils into
the tissues but also modulates the ability of these neu-
trophils to cross epithelial barriers and to kill pathogens.
In addition, TNF-a enhances the fungicidal properties
of neutrophils, promotes the adhesion of immune to
Table 2 The profile of proinflammatory cytokine and chemokine secretion of mDCs in response to C. parapsilosis
mDC (24 h)
(pg/ml) unstimulated Cp wt Cp lip-/-
IL-1 a 21.90† (6.64- 70.46) 241.71 (19.78- 366.12) 487.97# (110.80- 548.77)
IL-6 159.26 (38.75- 226.87) 3934.41 (2481.7-6316.06) 6535.23# (3122.14-9215.14)
TNF a 99.51 (58.12-158.89) 1724.67 (736.08-2859.76) 3454.13# (2934.29-4139.50)
CXCL8 1632.81 (1358.45-2897.26) 3420.32 (3268-6563.96) 2657.64 (1846.33-3076.52)
mDC (48 h)
(pg/ml) unstimulated Cp wt Cp lip-/-
IL-1 a 22.97 (11.17-40.30) 35.58 (11.19-68.98) 126.87# (59.90-198.21)
IL-6 4364.11 (4025.97-5410.58) 5873.19 (4767.13-7510.32) 7988.22# (6119.10-9893.27)
TNF a 124.92 (74.93-163.21) 3456.54 (1628.19-5686.98) 4345.39 (2694.78-5426.10)
CXCL8 2223.11 (898.14-4978.58) 2605.43 (1254.21-5297.94) 2392.44 (1226.74-5394.56)
n = 8 independent blood donors.
Mature dendritic cells were stimulated with C. parapsilosis wild type (Cp wt), lipase deficient (Cp lip-/-) cells or left unstimulated. Secretion of IL-1a, IL-6, TNF-a or
CXCL8 by iDCs was determined by Luminex analyzer or ELISA at 24 h and 48 h post-infection. †: medians (interquartile ranges) # p < 0.05.
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endothelial cells and acts as a danger signal. Corre-
sponding to this finding, we found that DCs infected
with lipase deficient yeast cells displayed increased pro-
tease activity, which accompanies cell death and the
release of danger signals. Finally, TNF-a, IL-1a and IL-6
are also implicated in the induction of antimicrobial
peptide expression in epithelial cells [27]. Taken
together, the secretion of pro-inflammatory mediators
and the release of danger signals by DCs as a response
to C. parapsilosis may play a crucial role in the recruit-
ment of immune cells into the sites of infection.
Conclusions
Our work shows that C. parapsilosis activates monocyte-
derived DCs, as demonstrated by increased phagocytosis
and killing of yeast cells and proinflammatory protein
secretion. Moreover, we found that DCs infected with
lipase deficient C. parapsilosis are functionally more
potent relative to DCs infected with wild type yeast cells,
which suggests that lipase interferes with DC activation.
This finding was unexpected because lipases of other
pathogenic microorganisms are considered to be indu-
cers of immune response, consequently one would have
predicted a decreased activation phenotype in response
to lipase deficient C. parapsilosis. The fact that this was
not the case appears to result, at least in part, the DC
activation is suppressed by the C. parapsilosis lipase.
Further studies will be required to identify the defective
anti-C. parapsilosis effector mechanisms that increase
susceptibility to invasive candidiasis and to determine
how C. parapsilosis lipase represses immune activation.
Methods
Fungal Strains and culture conditions
Candida parapsilosis GA1 and lipase deficient (ΔCplip1-
ΔCplip2/ΔCplip1-ΔCplip2::FRT) strains [13] were main-
tained at -80°C in 35% glycerol. If not mentioned other-
wise, the cells were grown in YPD (1% yeast extract, 2%
bactopeptone, 2% glucose).
Monocyte isolation and dendritic cell differentiation
Human peripheral blood mononuclear cells (PBMCs)
were isolated from buffy coat blood samples from
healthy donors by Ficoll Paque Plus (GE Healthcare)
density gradient centrifugation. Monocytes were isolated
by adherence on tissue culture plastic plates. Immature
dendritic cells were prepared by culturing monocytes for
five days with 1000 U/ml human recombinant granulo-
cyte-macrophage colony stimulating factor (GM-CSF;
Sigma) and 1000 U/ml human recombinant interferon-a
(IFN-a; Sigma) in RPMI-1640 medium (Gibco) comple-
mented with 10% heat-inactivated FBS (Gibco) and 1%
penicillin/streptomycin solution (Gibco) in 6-well tissue
culture plate (Sarstedt). Mature dendritic cells were
obtained from immature dendritic cells by stimulation
with 10 ng/ml recombinant TNFa (R&D Systems) for
24 hours.
In vitro infection
For infections, iDC and mDC cells were co-incubated
with C. parapsilosis cells at effector-to-target ratios of
1:5 in six-well plates. Samples were incubated for var-
ious time at 37°C and 5% (v/v) CO2. For gene expres-
sion studies DCs were harvested after 1 h and 24 h co-
incubations, for cytokine measurement supernatants
were collected after 24 h and 48 h.
Killing assays
Co-cultures of the DCs and C. parapsilosis were per-
formed according to our described protocol [13] with
some modifications. Briefly, C. parapsilosis cells were
grown overnight, washed three times in PBS, counted
using a hematocytometer, and suspended in RPMI-1640
medium (Gibco). The cells were then co-incubated with
DCs as described above. As a control, the same number
of C. parapsilosis cells were inoculated in the RPMI-
1640 medium (Gibco) complemented with 10% heat-
inactivated FBS (Gibco) and 1% penicillin/streptomycin
solution (Gibco) with no effector cells. The wells were
then incubated at 37°C for 3 h, and washed three times
with PBS to remove nonadherent Candida cells. Yeast
cells were liberated from DCs by forcibly disrupting the
DCs through pipetting them in distilled water for 2 min.
The yeast cells were collected, counted, and serially
diluted prior to being plated. Cells were plated in YPD
agar and incubated for 3 days at 30°C. The killing effi-
ciency was calculated by normalizing the number of
CFU (colony forming unit) counted from the DC
infected wells to the total number of CFU of C. parapsi-
losis detected from the control wells, and multiplied by
100 for percentage.
Phagocytosis assays
Infections were performed as described above and the
phagocytosis was monitored by fluorescent microscope
after 1 h of co-incubation. Briefly, DCs were treated
with FITC-labeled C. parapsilosis wild type or homozy-
gous lipase deletion mutant for 1 h. Cells were then
trypsinized by using TrypLe Express (Gibco), and
washed with PBS. The fluorescence of extracellular
yeasts was quenched with 0,4% Trypan blue solution. In
some experiments labelling with calcofluor white (0,1
ng/ml (w/v)) was also performed in order to define non-
phagocytosed yeast cells (data not shown). After two
washes with PBS, cell suspensions were loaded up in
each cuvette of a cytospin (Cellspin I, Tharmac). The
cells were collected at 600 rpm for 6 minutes and then
fixed in PBS with 4% paraformaldehyde for 15 min. The
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samples were then permeabilized with PBS containing 1%
Triton-X (Sigma) for 30 minutes and blocked in PBS
containing 1% BSA for 20 minutes. Samples were incu-
bated with 1:10 dilution of phycoeritrin (PE) conjugated
anti-CD83 antibody (Life Technologies) in PBS contain-
ing 1% BSA and 0.1% Triton-X for 1 h and washed three
times with PBS for 5 min each. Negative controls con-
sisted of incubation with isotype matched control (Life
Technologies). Finally, samples were washed with PBS
containing 4’,6-diamidino-2-phenylindole (DAPI) and
mounted in Citifluor mounting media (Citifluor Ltd.).
Samples were analyzed using epifluorescent illumination
of the Axiovision Z1 Fluorescent Microscope (Zeiss) and
images recorded by Axiovision software. The percent of
phagocytosis was the ratio of the number of DCs that
ingested yeast to the total number of DCs multiplied by
100. Phagocytic index was the ratio of the number of
intracellular yeast cells to the number of DCs which pha-
gocytozed at least one yeast cell. The number of total
DCs, DCs containing yeast cells and ingested C. parapsi-
losis cells were determined from ten individual fields.
Flow cytometry analysis
Treatment and harvesting of DCs with FITC-labeled C.
parapsilosis strains was performed as described above.
The fluorescence of extracellular yeasts was quenched
with 0,4% Trypan blue solution. Cells were washed
twice with FACS buffer (2% FBS and 0,5 mM EDTA in
PBS). Cells were then incubated with 1:10 dilution of
phycoeritrin conjugated anti-CD83 antibody or an iso-
type matched control (Life Technologies) for 30 minutes
at 4°C. Cells were fixed with FACS fix solution (2% FBS,
0,5 mM EDTA and 4% paraformaldehyde in PBS) and
analyzed on a FACS Calibur Flow Cytometer (Becton
Dickinson) using CellQuest Pro software.
Lysosome maturation assays
Infections were performed as described above and lyso-
some maturation was monitored by fluorescent micro-
scopy after 1 h of co-incubation. Briefly, DCs were treated
with wild type or a homozygote lipase deletion mutant
FITC-labeled C. parapsilosis. After 1 h co-incubation the
cell culture media was replaced by fresh media supple-
mented with 50nM LysoTracker Red (Life Technologies)
and incubated for additional 45 minute. Cells were then
spun and mounted as described in phagocytosis assay sec-
tion. Samples were analyzed using epifluorescent illumina-
tion of the Axiovision Z1 Fluorescent Microscope (Zeiss)
and images recorded by Axiovision software.
Cell viability assays
Treatment and harvesting of DCs with C. parapsilosis
strains was performed as described above. After 1 and
24 hours co-incubation, cells were transferred into 96-
well U-bottom opaque plate (Greiner). Dead-cell pro-
tease activity was measured using Cyto Tox-Glo Cyto-
toxicity Assay (Promega) following the manufacturer’s
instructions. Luciferase activity was measured by micro-
plate luminometer (LUMIStar Optima, BMG Labtech).
Quantitative reverse transcriptase polymerase chain
reaction (QRT-PCR)
Total RNA was extracted from DCs using RNeasy Plus
Mini Kits (Qiagen) according to the manufacturer’s
instruction. The quality and quantity of the extracted
RNA was determined using NanoDrop (Thermo Scienti-
fic), Qubit (Life Technologies) and Bioanalyzer (Agilent)
measurements. cDNA was synthesized from 150ng of total
RNA by using High Capacity RNA to cDNA Kit (Life
Technologies) on a Veriti Thermal Cycler (Life Technolo-
gies). TaqMan technology based real-time quantitative
PCR was used to quantify the relative abundance of each
mRNA (StepOne Plus Real-Time PCR System; Life Tech-
nologies). For this, specific exon spanning gene expression
assays were used for IL-1a (Hs00174092_m1), IL-6
(Hs00174131_m1), TNFa (Hs00174128_m1), CXCL8
(Hs00174103_m1) and 18S rRNA (Hs99999901). As con-
trols, we used the reaction mixtures without the cDNA.
All measurements were preformed in duplicate for each
experiment with at least three biological replicates. The
ratio of each mRNA relative to the 18S rRNA was calcu-
lated using the ΔΔCT method.
Measurement for secreted cytokine levels
Harvested cell culture supernatants were centrifuged
and the concentrations of secreted IL-1a, IL-6 and
TNF-a were measured by Fluorokine Multianalyte Pro-
filing (MAP) Kits (R&D Systems, Inc.) on a Luminex
analyzer (Luminex Corp.), according to the manufac-
turer’s instruction. CXCL8, IL-1a, IL-6 and TNFa pro-
teins were also measured using the Quantikine human
immunoassay kits (R&D Systems, Inc.) following the
manufacturer’s instructions. We used serial dilutions of
the respective recombinant human proteins for generat-
ing standard curves. The optical density of the wells was
determined using a microplate reader (FLUOstar
Optima, BMG Labtech) set to 450 nm with a wave-
length correction set to 540 nm.
Statistical analysis
The significance of differences between sets of data was
determined by Newman-Keuls test or ANOVA accord-
ing to the data by using GraphPad Prism version 5.02
for Windows (California, USA).
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